<unk> (oral) is a proton pump inhibitor that is FDA approved for the treatment of short-term treatment of erosive esophagitis associated with gastroesophageal reflux disease (GERD), maintenance of healing of erosive esophagitis, pathological hypersecretory conditions including Zollinger-Ellison Syndrome..   Common adverse reactions include headache, diarrhea, nausea, abdominal pain, vomiting, flatulence, dizziness, arthralgia, URI, fever, and rash.
Pantoprazole 
Lansoprazole
Rabeprazole
Omeprazole
Esomeprazole 
Esomeprazole sodium
Sucralfate
Hexetidine